These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1352060)
1. Modulation of MK-801 response by dopaminergic agents in mice. Verma A; Kulkarni SK Psychopharmacology (Berl); 1992; 107(2-3):431-6. PubMed ID: 1352060 [TBL] [Abstract][Full Text] [Related]
2. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Lapin IP; Rogawski MA Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905 [TBL] [Abstract][Full Text] [Related]
3. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors. Ferré S; Giménez-Llort L; Artigas F; Martínez E Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043 [TBL] [Abstract][Full Text] [Related]
4. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Huang KX; Walters JR J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977 [TBL] [Abstract][Full Text] [Related]
5. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. Svensson A; Carlsson A; Carlsson ML J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051 [TBL] [Abstract][Full Text] [Related]
6. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats. Verma A; Kulkarni SK Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866 [TBL] [Abstract][Full Text] [Related]
7. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. Goodwin P; Starr BS; Starr MS J Neural Transm Park Dis Dement Sect; 1992; 4(1):15-26. PubMed ID: 1531757 [TBL] [Abstract][Full Text] [Related]
8. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Singh NA; Bush LG; Gibb JW; Hanson GR Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780 [TBL] [Abstract][Full Text] [Related]
9. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice. Kim HS; Rhee GS; Oh S; Park WK Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060 [TBL] [Abstract][Full Text] [Related]
10. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine. Starr MS; Starr BS J Neural Transm Park Dis Dement Sect; 1993; 6(3):215-26. PubMed ID: 7907216 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice. Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626 [TBL] [Abstract][Full Text] [Related]
12. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Arnt J Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283 [TBL] [Abstract][Full Text] [Related]
13. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Wedzony K; Czyrak A; Maćkowiak M; Fijał K Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801. Olds ME Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611 [TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
16. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237 [TBL] [Abstract][Full Text] [Related]
17. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse. Starr MS; Starr BS Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652 [TBL] [Abstract][Full Text] [Related]
18. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice. Verma A; Kulkarni SK Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182 [TBL] [Abstract][Full Text] [Related]
19. Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors. Võikar V; Soosaar A; Volke V; Kõks S; Bourin M; Männistö PT; Vasar E Eur Neuropsychopharmacol; 1999 Dec; 9(6):507-14. PubMed ID: 10625119 [TBL] [Abstract][Full Text] [Related]
20. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Dall'Olio R; Gandolfi O; Montanaro N Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]